• Pharma
  • May 13, 2019
  • 246 views
Large pharma companies increase prices ofgeneric drugs by up to one thousand percent

Leading drug companies including Teva, Pfizer, Novartis and Mylan conspired to inflate the prices of generic drugs by as much as 1,000 percent, according to a far-reaching lawsuit filed on…

  • Pharma
  • May 10, 2019
  • 259 views
The Supreme Court arrived against the nomination rejection PS Chatwal will keep its favour

Torak Pharmaceutical company managing director PS Chatwal has now appealed to the Supreme Court against the rejection of the nomination. Chatwal said that the election commission has also been in…

  • Pharma
  • May 10, 2019
  • 328 views
Medlife acquires Myra, to expand medicine delivery service

Medlife, which operates an online pharmacy and healthcare platform, has acquired Bengaluru’s medicine delivery startup Myra Medicines. The deal will help Medlife scale Myra’s express delivery service across its own…

  • Pharma
  • May 4, 2019
  • 249 views
NPPA fixes retail prices of 22 formulations under DPCO, 2013

Name of the formulations are mesalazine sachet, clotrimazole+ beclomethasone+ neomycin cream, telmisartan +cilnidipine+ chlorthalidone tablet, paracetamol +phenylephrine+caffeine (Anhydrous)+ diphenhydramine tablet, methylcobalamin+ pyridoxine + folic acid tablet, medoxomil + amlodipine +…

  • Pharma
  • May 1, 2019
  • 223 views
Biocon Bets Fired On Biosimilar For Revenue Growth

Searing growth in its biosimilar business is expected to help see Biocon cross $1 billion in revenue this fiscal. Biosimilars, or biologics, are biological drugs that are developed to be…

  • Pharma
  • May 1, 2019
  • 190 views
Price War In Anti Diabetic Medicine Segment

A price war is brewing in India’s growing diabetes drug market, drawing comparisons with the recent tariff battles in the telecom sector. Glenmark Pharmaceuticals NSE -1.45 % has launched a patented…

  • Pharma
  • April 17, 2019
  • 230 views
Many essential drugs priced much higher than manufacturing cost: WHO

NEW DELHI: Around 40% of the essential medicines in India with lowest MRP are priced significantly higher than estimated production costs, an assessment by the World Health Organisation (WHO) shows…

  • Pharma
  • April 17, 2019
  • 237 views
Medicines sold in market and supplied to hospitals at very different prices

Srinagar: An official document mentioning the rate list of various drugs procured for hospitals in Jammu & Kashmir shows shocking discrepancy between prices at which the drugs are bought for…

  • Pharma
  • April 16, 2019
  • 258 views
Ready-to-Infuse Therapy Available for Patients with Certain Cancers

Sun Pharma’s gemcitabine in sodium chloride injection (Infugem), for intravenous use, is now commercially available in the United States. This is the first chemotherapy product that comes in a premixed,…

  • Pharma
  • April 12, 2019
  • 253 views
Combination drug market declines 56% in March as govt clamps down

With the government clamping down on combination drugs, the latest market data shows that in March the fixed dose combination (FDC) market declined by 56.4 per cent, when the non-FDC…